Novel targets for slowing CKD progression

被引：7
|
作者：
Carrero, Juan Jesus [1 ]
Stenvinkel, Peter [1 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Renal Med, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden
来源：
NATURE REVIEWS NEPHROLOGY | 2011年 / 7卷 / 02期
关键词：
CHRONIC KIDNEY-DISEASE; LONG-TERM OUTCOMES; BICARBONATE; RISK;
D O I：
10.1038/nrneph.2010.177
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
several 2010 trials have provided novel information on how best to manage patients with predialysis chronic kidney disease (ckd). armed with these new findings, nephrologists can find new means of slowing ckd progression by targeting blood-pressure control, acidosis and serum uric acid levels.
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [21] Niacin and Progression of CKD
    Streja, Elani
    Kovesdy, Csaba P.
    Streja, Dan A.
    Moradi, Hamid
    Kalantar-Zadeh, Kamyar
    Kashyap, Moti L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (05) : 785 - 798
  • [22] Complications of Progression of CKD
    Yang, Min
    Fox, Chester H.
    Vassalotti, Joseph
    Choi, Michael
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2011, 18 (06) : 400 - 405
  • [23] Metabolic syndrome severity score and the progression of CKD
    Wu, Mingyang
    Shu, Yanling
    Wang, Lulin
    Song, Lulu
    Chen, Shuohua
    Liu, Yunyun
    Bi, Jianing
    Li, Dankang
    Yang, Yingping
    Hu, Yonghua
    Wang, Youjie
    Wu, Shouling
    Tian, Yaohua
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (01)
  • [24] Urinary Sodium and Potassium Excretion and CKD Progression
    He, Jiang
    Mills, Katherine T.
    Appel, Lawrence J.
    Yang, Wei
    Chen, Jing
    Lee, Belinda T.
    Rosas, Sylvia E.
    Porter, Anna
    Makos, Gail
    Weir, Matthew R.
    Hamm, L. Lee
    Kusektt, John W.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (04): : 1202 - 1212
  • [25] Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: COMMENTARY Comment
    Paueksakon, Paisit
    Fogo, Agnes B.
    KIDNEY360, 2022, 3 (07): : 1141 - 1143
  • [26] Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
    Chen, Lin
    Yang, Tian
    Lu, De-Wen
    Zhao, Hui
    Feng, Ya-Long
    Chen, Hua
    Chen, Dan-Qian
    Vaziri, Nosratola D.
    Zhao, Ying-Yong
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 670 - 681
  • [27] Slowing progression of chronic kidney disease
    Drawz, Paul E.
    Rosenberg, Mark E.
    KIDNEY INTERNATIONAL SUPPLEMENTS, 2013, 3 (04) : 372 - 376
  • [28] Slowing the progression of chronic kidney disease
    Herrington, William G.
    Mason, Phil D.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (11) : 634 - 638
  • [29] A predictive model for progression of CKD
    Chang, Hsueh-Lu
    Wu, Chia-Chao
    Lee, Shu-Pei
    Chen, Ying-Kai
    Su, Wen
    Su, Sui-Lung
    MEDICINE, 2019, 98 (26)
  • [30] Proteomics of CKD progression in the chronic renal insufficiency cohort
    Dubin, Ruth F.
    Deo, Rajat
    Ren, Yue
    Wang, Jianqiao
    Zheng, Zihe
    Shou, Haochang
    Go, Alan S.
    Parsa, Afshin
    Lash, James P.
    Rahman, Mahboob
    Hsu, Chi-yuan
    Weir, Matthew R.
    Chen, Jing
    Anderson, Amanda
    Grams, Morgan E.
    Surapaneni, Aditya
    Coresh, Josef
    Li, Hongzhe
    Kimmel, Paul L.
    Vasan, Ramachandran S.
    Feldman, Harold
    Segal, Mark R.
    Ganz, Peter
    CRIC Study Investigator
    CKD Biomarkers Consortium
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345